Technology area: Biotechnology & Pharmaceuticals
19 pending office actions • 16 clients • 19 examiners • 15 art units • 0 of 19 (0%) have an AI response strategy ready
WIGGIN AND DANA LLP operates within the Biotechnology & Pharmaceuticals sector, a field often characterized by rigorous examination standards. The firm has handled 2008 career applications, achieving a resolved allowance rate of 78.28 percent. This rate reflects the firm's ability to secure intellectual property rights in a highly technical and competitive landscape. The prosecution process at the firm involves an average of 3.26 office actions per allowance, which indicates a more iterative engagement with patent examiners compared to less complex technology areas.
With 16 pending office actions currently on the docket, the firm continues to manage its portfolio through the detailed requirements of the USPTO. The 78.28 percent allowance rate serves as a benchmark for its performance in the specialized Biotechnology & Pharmaceuticals domain. For practitioners, the average of 3.26 office actions per allowance suggests that while the path to a grant is not immediate, the firm possesses the persistence necessary to overcome technical rejections. This historical data from 2008 career applications provides a reliable indicator of the firm's capacity to navigate the life sciences patent landscape effectively.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (21%) |
| §103 only | 6 (32%) |
| §102 only | 1 (5%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 3 (16%) |
| Multi-statute (no §101) | 4 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NELSON, FREDA ANN | 1 | 42.8% | +7.7% |
| BARNES JR, CARL E | 1 | 33.3% | +25.2% |
| HE, JIALONG | 1 | 81.4% | +32.9% |
| KANE, KATHARINE GRACZ | 1 | 47.7% | +45.7% |
| SHOMER, ISAAC | 1 | 63.2% | +30.4% |
| DIVELBISS, MATTHEW H | 1 | 24.0% | +25.2% |
| ZHANG, SHIRLEY X | 1 | 69.8% | +14.2% |
| DIXON, ANNETTE FREDRICKA | 1 | 74.4% | +26.0% |
| LAGOY, KYRA RAND | 1 | 9.5% | -11.1% |
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +39.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628457 | PLATFORM FOR DETERMINING A COMPETENCY SCORE | LAGOY, KYRA RAND | 138d overdue |
| 18357854 | Stored Program Interpreter For Implementing Time-Dependent Behavior of Controlled Loads | GOORAY, MARK A | 87d overdue |
| 18939439 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM | SHOMER, ISAAC | 42d overdue |
| 17672435 | Microprocessor Including a Model of an Enterprise | CRANDALL, RICHARD W. | 2d overdue |
| 19185744 | LOCATION VERIFICATION SYSTEM AND METHOD OF VERIFYING A LOCATION OF AN ENTITY | NELSON, FREDA ANN | — |
| 18881787 | METHODS AND SYSTEMS FOR REAL-TIME TRANSLATION | HE, JIALONG | — |
| 18899973 | APPARATUS AND METHOD FOR GENERATING SYSTEM IMPROVEMENT DATA | DIVELBISS, MATTHEW H | — |
| 17696635 | Rocking Bioreactor with Integrated Monitoring Probe System | LOPEZLIRA, ASHLEY NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18939439 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM | SHOMER, ISAAC | 42d overdue |
| 19010621 | ADAPTIVE FOOTWARE APPARATUS FOR ACCOMMODATING ANKLE-FOOT ORTHOSIS | KANE, KATHARINE GRACZ | 13d |
| 19076194 | APPARATUS AND METHOD FOR ADAPTIVE DATA STRUCTURE GENERATION | BARNES JR, CARL E | — |
| 18881787 | METHODS AND SYSTEMS FOR REAL-TIME TRANSLATION | HE, JIALONG | — |
| 18899973 | APPARATUS AND METHOD FOR GENERATING SYSTEM IMPROVEMENT DATA | DIVELBISS, MATTHEW H | — |
| 18775568 | APPARATUS AND METHOD FOR COMMUNICATIONS ASSOCIATED WITH ONE OR MORE DATA SETS | ZHANG, SHIRLEY X | — |
| 18664739 | PATIENT RESPIRATORY MASK WITH INTEGRATED MICROPHONE AND METHOD OF PATIENT COMMUNICATION UTILIZING THE SAME | DIXON, ANNETTE FREDRICKA | — |
| 18368240 | METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS | NOBLE, MARCIA STEPHENS | — |
| Art Unit | Apps |
|---|---|
| 1799 | 2 |
| 2178 | 1 |
| 3732 | 1 |
| 1612 | 1 |
| 3624 | 1 |
| 2447 | 1 |
| 3685 | 1 |
| 1632 | 1 |
| 2199 | 1 |
| 1622 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19185744 | LOCATION VERIFICATION SYSTEM AND METHOD OF VERIFYING A LOCATION OF AN ENTITY | The Web Genie Inc. | NELSON, FREDA ANN | §101§103 | Non-Final OA | — | Pending | Apr 22, 2025 | |
| 19076194 | APPARATUS AND METHOD FOR ADAPTIVE DATA STRUCTURE GENERATION | Mary Street Group Enterprises, Inc. | BARNES JR, CARL E | 2178 | §103 | Final Rejection | — | Pending | Mar 11, 2025 |
| 18881787 | METHODS AND SYSTEMS FOR REAL-TIME TRANSLATION | Lucca Ventures, Inc. | HE, JIALONG | §102§103§112 | Non-Final OA | — | Pending | Jan 07, 2025 | |
| 19010621 | ADAPTIVE FOOTWARE APPARATUS FOR ACCOMMODATING ANKLE-FOOT ORTHOSIS | Kompass Kicks LLC | KANE, KATHARINE GRACZ | 3732 | §103 | Final Rejection | 13d | Pending | Jan 06, 2025 |
| 18939439 | AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM | Cila Therapeutics Inc. | SHOMER, ISAAC | 1612 | §103§112 | Final Rejection | 42d overdue | Pending | Nov 06, 2024 |
| 18899973 | APPARATUS AND METHOD FOR GENERATING SYSTEM IMPROVEMENT DATA | The Blue Collar Success Group, LLC | DIVELBISS, MATTHEW H | 3624 | §103 | Final Rejection | — | Pending | Sep 27, 2024 |
| 18775568 | APPARATUS AND METHOD FOR COMMUNICATIONS ASSOCIATED WITH ONE OR MORE DATA SETS | Dreamguard Inc. | ZHANG, SHIRLEY X | 2447 | §102Other | Final Rejection | — | Pending | Jul 17, 2024 |
| 18664739 | PATIENT RESPIRATORY MASK WITH INTEGRATED MICROPHONE AND METHOD OF PATIENT COMMUNICATION UTILIZING THE SAME | Lucca Ventures, Inc. | DIXON, ANNETTE FREDRICKA | §102§103§112DP | Non-Final OA | — | Pending | May 15, 2024 | |
| 18628457 | PLATFORM FOR DETERMINING A COMPETENCY SCORE | Firefly Lab, LLC | LAGOY, KYRA RAND | 3685 | §101§103 | Final Rejection | 138d overdue | Pending | Apr 05, 2024 |
| 18368240 | METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS | Regen Theranostics, Inc. | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18357854 | Stored Program Interpreter For Implementing Time-Dependent Behavior of Controlled Loads | Astronics Advanced Electronic Systems Corp. | GOORAY, MARK A | 2199 | §101§112 | Final Rejection | 87d overdue | Pending | Jul 24, 2023 |
| 18033194 | ADMINISTRATION OF ANTIPURINERGIC COMPOSITIONS FOR TREATING NERVOUS SYSTEM DISORDERS | Paxmedica, Inc. | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §102§103§112DPOther | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18023686 | INHALABLE THERAPEUTIC AGENTS | Cila Therapeutic Inc. | STEVENS, MARK V | 1613 | §103DP | Final Rejection | 88d overdue | Pending | Feb 27, 2023 |
| 17893279 | Laser speckle imaging for live cell quantification | Nirrin Technologies, Inc. | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Final Rejection | — | Pending | Aug 23, 2022 |
| 17696635 | Rocking Bioreactor with Integrated Monitoring Probe System | Nirrin Technologies, Inc. | LOPEZLIRA, ASHLEY NICOLE | 1799 | §102§103§112 | Non-Final OA | — | Pending | Mar 16, 2022 |
| 17672435 | Microprocessor Including a Model of an Enterprise | Dimitris Lyras | CRANDALL, RICHARD W. | 3619 | §101§103§112 | Non-Final OA | 2d overdue | Pending | Feb 15, 2022 |
| 17297571 | METHOD AND SENSOR FOR DETERMINING A VALUE INDICATING THE IMPEDANCE OF A SUSPENSION | Hamilton Bonaduz AG | SAUNCY, TONI DIAN | 2863 | §103 | Non-Final OA | 26d | Pending | Jan 18, 2022 |
| 17343896 | DEVICE AND METHOD FOR AN INTRAOPERATIVE CANCER DETECTOR | Orfactory, Inc. | TOWA, RENE T | 3791 | §103 | Final Rejection | — | Pending | Jun 10, 2021 |
| 17337055 | Disposable Cell for In Situ Monitoring Probe | Nirrin Technologies, Inc. | HASSAN, LIBAN M | 1799 | §102§103 | Non-Final OA | — | Pending | Jun 02, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial